Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Workers Comp

499 posts found

CWCI Explores Integration of COVID-19 Claims

COVID-19 claim data was gathered in a survey to understand impacts to comp.
Read More

Saliva Test with At-Home Collection Authorized

Saliva samples collected at-home must be sent to the designated lab.
Read More

FDA Approves Elyxyb Oral Solution for Migraines

Elyxyb (celecoxib) is an NSAID for the acute treatment of migraine with or without aura.
Read More

Live Better, Heal Better: Employee Wellness in Workers' Comp

How comorbidities, fatigue, and mental health impact claims management.
Read More

Texas Reminds Providers Certain Exams Must Be Done in Person

Maximum medical improvement (MME) and impairment rating (IR) evaluations cannot be done remotely.
Read More

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.
Read More

IQVIA Reports on Healthcare Shifts in the COVID-19 Era

A new study explores patients’ use of health services, the impact on medicine use, research activity, and more.
Read More

California Executive Order Greatly Expands COVID-19 Presumption

Many states expanded workers’ comp for COVID-19, but California casts a wider net.
Read More

NCCI Publishes COVID-19 Resource Center

Lists of compiled information on telehealth, public notices, and more.
Read More

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Read More

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Read More

California State Fund Establishes Two New Funds for COVID-19

$25 million each for essential worker and essential business support funds.
Read More
1 2 3 4 5 21 22 23 24 25 30 31 32 33 34
lockmap-markermagnifiercrossmenuarrow-rightcross-circle